The Kirklin Clinic

Birmingham, Alabama 35294

4 studies enrolling now · 25 studies all time

What they study most

Arterial Occlusive Diseases, Breast Benign Tumor, Breast Cancer, Breast Malignant Tumor, Breast Neoplasm, Cancer, Cardiovascular Disease, Chronic Hepatitis C, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Dermatophytosis, Evaluation of Jublia on Nail Polish With Healthy Toenails, Graft Occlusion, Vascular

Studies at this site

• Regulation of Inflammatory Genes in Psoriasis — Recruiting now
• Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE) — Recruiting now
• Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness — Recruiting now
• Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction — Recruiting now
• Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction — Completed
• Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis — Completed
• TLR4 Polymorphisms and Risk of Skin Cancer — Completed
• An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
• An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension — Completed
• Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Real-World Evaluation of the Effect of Jublia on Nail Polish — Completed
• Study Evaluating the Effect of Jublia on Dermatophytomas — Completed
• Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography — Completed
• Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir — Completed
• Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications — Completed
• Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT — Completed
• Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection — Completed
• Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke — Stopped early
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures — Completed